Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(11%)
Results Posted
33%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
5
56%
Ph phase_2
2
22%
Ph phase_4
1
11%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(3)
Terminated(2)
Other(2)

Detailed Status

Completed3
unknown2
Active, not recruiting1
Terminated1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (25.0%)
Phase 41 (12.5%)
N/A5 (62.5%)

Trials by Status

completed333%
active_not_recruiting111%
terminated111%
unknown222%
withdrawn111%
not_yet_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9